MiR-874 has been found to alleviate diabetic retinopathy in a murine model by regulating the NF-κB signaling pathway [64], ameliorating renal injury in diabetic nephropathy [65], and providing neuroprotection in a stroke model [66]. This evidence concerns the gene NFKB1 and diabetic kidney disease.